Celldex Therapeutics Inc Stock Performance
as on April 24, 2026 at 1:09 am IST
Day's Low
Day's High
$34.22$34.96
0.29%
Downside
1.86%
Upside
52 Week's Low
52 Week's High
$17.85$35.7947.99%
Downside
4.28%
Upside
Celldex Therapeutics Inc share price movements today
- Previous Close
- $34.21
- Open
- $34.51
- Volume
- 38.4K
- Day's Low - High
- $34.22 - $34.96
- 52 Week Low - High
- $17.85 - $35.79
Celldex Therapeutics Inc Historical Returns
- 1 Month Return
- + 7.58 %
- 3 Month Return
- + 31.98 %
- 1 Year Return
- + 76.07 %
- 3 Year Return
- -6.58 %
- 5 Year Return
- + 22.66 %
Celldex Therapeutics Inc Stock Fundamentals & Key Indicators
Check Celldex Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.7B
EPS (TTM)
-4.733
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-284.0M
Revenue (TTM)
1.5M
Profit Margin
0.00%
Return On Equity TTM
-40.62%
Celldex Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Celldex Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.7B | 22.66% | NA | 0.00% | |
| BUY | $41.2B | 127.17% | 131.81 | 8.45% | |
| BUY | $111.1B | 100.86% | 28.5 | 32.94% | |
| NA | $34.7B | NA | 126.48 | 5.37% | |
| BUY | $79.0B | 52.79% | 18.02 | 31.41% |
Stock Returns calculator for Celldex Therapeutics Inc Stock including INR - Dollar returns
The Celldex Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Celldex Therapeutics Inc investment value today
Current value as on today
₹1,95,100
Returns
₹95,100
(+95.1%)
Returns from Celldex Therapeutics Inc Stock
₹76,634 (+76.63%)
Dollar Impact
₹18,466 (+18.47%)
Analyst Recommendation on Celldex Therapeutics Inc Stock
Based on 14 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Celldex Therapeutics Inc. Average target price of $57
Celldex Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Celldex Therapeutics Inc.
What analysts predicted
39.79%UPSIDE
Target Price
$57
Current Price
$34.32
Analyzed by
14 Analysts
Target
$57.00
Celldex Therapeutics Inc target price $57, a slight upside of 39.79% compared to current price of $34.32. According to 14 analysts rating.
Celldex Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Celldex Therapeutics Inc Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:10% versus previous 30 day period
Celldex Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Celldex Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Celldex Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Celldex Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Celldex Therapeutics Inc News & Key Events
Today's Timeline - 09 September
Tue, 06:31 PM
-Celldex Therapeutics to present at Morgan Stanley Healthcare Conference today at 3:20 PM ET.
Insights on Celldex Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, CLDX has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 3 months, CLDX stock has moved up by 32.0%
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 48.4% return, outperforming this stock by 55.0%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 730.0K → 75.0K (in $), with an average decrease of 89.7% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 8 quarters, -32.80M → -81.36M (in $), with an average decrease of 14.0% per quarter
About Celldex Therapeutics Inc
| Organisation | Celldex Therapeutics Inc |
| Headquarters | Perryville III Building, Hampton, NJ, United States, 08827 |
| Industry | Biotechnology |
| CEO | Mr. Anthony S. Marucci M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Celldex Therapeutics Inc
Name | Title |
|---|---|
Ms. Elizabeth Crowley | Chief Product Development Officer & Senior VP |
Prof. Joseph P. Schlessinger Ph.D. | Co-Founder & Member of Scientific Advisory Board |
Dr. Ronald A. Pepin Ph.D. | Chief Business Officer & Senior VP |
Dr. Diane C. Young M.D. | Senior VP & Chief Medical Officer |
Dr. Tibor Keler Ph.D. | Founder, Chief Scientific Officer & Executive VP |
Mr. Sam Martin CPA | Senior VP, CFO, Secretary & Treasurer |
Ms. Sarah Cavanaugh | Senior Vice President of Corporate Affairs & Administration |
Mr. Freddy A. Jimenez Esq. | Senior VP & General Counsel |
Mr. Anthony S. Marucci M.B.A. | Founder, President, CEO & Director |
Dr. Margo Heath-Chiozzi M.D. | Senior Vice President of Regulatory Affairs |
FAQs
What is Celldex Therapeutics Inc share price today?
Celldex Therapeutics Inc share price today is $34.32 as on . Celldex Therapeutics Inc share today touched a day high of $34.96 and a low of $34.22.
What is the 52 week high and 52 week low for Celldex Therapeutics Inc share?
Celldex Therapeutics Inc share touched a 52 week high of $35.79 on and a 52 week low of $17.85 on . Celldex Therapeutics Inc stock price today i.e. is trending at $34.32,which is 4.11% down from its 52 week high and 92.27% up from its 52 week low.
What is Celldex Therapeutics Inc's market capitalisation today?
Celldex Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Celldex Therapeutics Inc Stock (CLDX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Celldex Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Celldex Therapeutics Inc Shares that will get you 0.0437 shares as per Celldex Therapeutics Inc share price of $34.32 per share as on April 23, 2026 at 7:39 pm IST.
What is the minimum amount required to buy Celldex Therapeutics Inc Stock (CLDX) from India?
Indian investors can start investing in Celldex Therapeutics Inc (CLDX) shares with as little as ₹94.085 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.85 in Celldex Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Celldex Therapeutics Inc share’s latest price of $34.32 as on April 23, 2026 at 7:39 pm IST, you will get 0.2914 shares of Celldex Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Celldex Therapeutics Inc has given to Indian investors in the last 5 years?
Celldex Therapeutics Inc stock has given 22.66% share price returns and 23.96% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?